IRADIMED CORP — Director's Dealing 2022

Dec 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2022-12-07

Reporting Person: HAWKINS JAMES B (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-07	Common Stock	M	2037	$28.56	Acquired	33527	Direct
2022-12-07	Common Stock	M	1035	$28.56	Acquired	34562	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-07	Restricted Stock Units	$	M	2037	Disposed		Common Stock (2037)	Direct
2022-12-07	Restricted Stock Units	$	M	1035	Disposed		Common Stock (1035)	Direct
2022-12-07	Restricted Stock Units	$	A	3501	Acquired		Common Stock (3501)	Direct

Footnotes

F1: Restricted Stock Units convert to common stock on a one-for-one basis.

F2: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F3: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F4: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.